[Data comparison of osteoporosis patients demonstrates nasal administration is not optimal].
D000281:Administration, Intranasal; D000284:Administration, Oral; D000336:Aerosols; D000368:Aged; D019386:Alendronate / Q000008:administration & dosage*; D002116:Calcitonin / Q000008:administration & dosage*; D012968:Etidronic Acid / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D005260:Female; D005598:Fractures, Spontaneous / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy*; D000068296:Risedronic Acid; D016896:Treatment Outcome
D000336:Aerosols; D002116:Calcitonin; D000068296:Risedronic Acid; D012968:Etidronic Acid; D019386:Alendronate